137 related articles for article (PubMed ID: 7947825)
1. Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa.
Bristol JA; Freedman SJ; Furie BC; Furie B
Biochemistry; 1994 Nov; 33(47):14136-43. PubMed ID: 7947825
[TBL] [Abstract][Full Text] [Related]
2. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
Wojcik EG; Van Den Berg M; Poort SR; Bertina RM
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594
[TBL] [Abstract][Full Text] [Related]
3. PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway.
Wasley LC; Rehemtulla A; Bristol JA; Kaufman RJ
J Biol Chem; 1993 Apr; 268(12):8458-65. PubMed ID: 8473289
[TBL] [Abstract][Full Text] [Related]
4. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site.
Bristol JA; Furie BC; Furie B
J Biol Chem; 1993 Apr; 268(10):7577-84. PubMed ID: 8463288
[TBL] [Abstract][Full Text] [Related]
5. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.
Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW
Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333
[TBL] [Abstract][Full Text] [Related]
6. Profactor IX propeptide and glutamate substrate binding sites on the vitamin K-dependent carboxylase identified by site-directed mutagenesis.
Sugiura I; Furie B; Walsh CT; Furie BC
J Biol Chem; 1996 Jul; 271(30):17837-44. PubMed ID: 8663364
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells.
Rehemtulla A; Roth DA; Wasley LC; Kuliopulos A; Walsh CT; Furie B; Furie BC; Kaufman RJ
Proc Natl Acad Sci U S A; 1993 May; 90(10):4611-5. PubMed ID: 8506307
[TBL] [Abstract][Full Text] [Related]
8. Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX.
Jorgensen MJ; Cantor AB; Furie BC; Brown CL; Shoemaker CB; Furie B
Cell; 1987 Jan; 48(2):185-91. PubMed ID: 3802193
[TBL] [Abstract][Full Text] [Related]
9. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
Liebman HA; Furie BC; Furie B
J Biol Chem; 1987 Jun; 262(16):7605-12. PubMed ID: 3108254
[TBL] [Abstract][Full Text] [Related]
10. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation.
Bristol JA; Ratcliffe JV; Roth DA; Jacobs MA; Furie BC; Furie B
Blood; 1996 Oct; 88(7):2585-93. PubMed ID: 8839851
[TBL] [Abstract][Full Text] [Related]
12. Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide.
Camire RM; Larson PJ; Stafford DW; High KA
Biochemistry; 2000 Nov; 39(46):14322-9. PubMed ID: 11087381
[TBL] [Abstract][Full Text] [Related]
13. Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties.
Ware J; Diuguid DL; Liebman HA; Rabiet MJ; Kasper CK; Furie BC; Furie B; Stafford DW
J Biol Chem; 1989 Jul; 264(19):11401-6. PubMed ID: 2738071
[TBL] [Abstract][Full Text] [Related]
14. The Arg-4 mutant factor IX Strasbourg 2 shows a delayed activation by factor XIa.
de la Salle C; Charmantier JL; Ravanat C; Ohlmann P; Hartmann ML; Schuhler S; Bischoff R; Ebel C; Roecklin D; Balland A
Nouv Rev Fr Hematol (1978); 1993; 35(5):473-80. PubMed ID: 8295821
[TBL] [Abstract][Full Text] [Related]
15. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.
Jacobs M; Freedman SJ; Furie BC; Furie B
J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250
[TBL] [Abstract][Full Text] [Related]
16. The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa.
Aktimur A; Gabriel MA; Gailani D; Toomey JR
J Biol Chem; 2003 Mar; 278(10):7981-7. PubMed ID: 12496253
[TBL] [Abstract][Full Text] [Related]
17. Protein engineering of the propeptide of human factor IX.
Handford PA; Winship PR; Brownlee GG
Protein Eng; 1991 Feb; 4(3):319-23. PubMed ID: 1857716
[TBL] [Abstract][Full Text] [Related]
18. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events.
Rabiet MJ; Jorgensen MJ; Furie B; Furie BC
J Biol Chem; 1987 Nov; 262(31):14895-8. PubMed ID: 3667614
[TBL] [Abstract][Full Text] [Related]
19. Multi-site-specificity of the vitamin K-dependent carboxylase: in vitro carboxylation of des-gamma-carboxylated bone Gla protein and Des-gamma-carboxylated pro bone Gla protein.
Benton ME; Price PA; Suttie JW
Biochemistry; 1995 Jul; 34(29):9541-51. PubMed ID: 7626624
[TBL] [Abstract][Full Text] [Related]
20. The gamma-carboxylation recognition site is sufficient to direct vitamin K-dependent carboxylation on an adjacent glutamate-rich region of thrombin in a propeptide-thrombin chimera.
Furie BC; Ratcliffe JV; Tward J; Jorgensen MJ; Blaszkowsky LS; DiMichele D; Furie B
J Biol Chem; 1997 Nov; 272(45):28258-62. PubMed ID: 9353278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
